1 / 9

Rational, Trial Design, and Results of the ADAGIO Delayed Start Trial

Mechanisms ● Mortality ● Therapeutics. Rational, Trial Design, and Results of the ADAGIO Delayed Start Trial.

melvin-dodson
Download Presentation

Rational, Trial Design, and Results of the ADAGIO Delayed Start Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mechanisms ● Mortality ● Therapeutics Rational, Trial Design, and Results of the ADAGIO Delayed Start Trial C. Warren Olanow, MD, FRCPCHenry P. and Georgette Goldschmidt ProfessorChairman Emeritus, Department of NeurologyProfessor, Department of NeuroscienceDirector, Robert and John M. Bendheim Parkinson's Disease CenterMount Sinai School of MedicineNew York, New York

  2. Schematic Illustration of the Three Primary End Points of the Study Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  3. Randomization and Treatment of the Study Subjects Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  4. Baseline Characteristics Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  5. Results for Primary and Secondary Characteristics Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  6. Changes in Scores on the Unified Parkinson’s Disease Rating Scale Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  7. Adverse Events According to Treatment Group Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  8. Adverse Events According to Treatment Group (cont) Olanow CW, et al. N Engl J Med 2009;361:1268-78.

  9. Adverse Events According to Treatment Group (cont) Olanow CW, et al. N Engl J Med 2009;361:1268-78.

More Related